Larvol Delta - Callio-Therapeutics-Doses-First-Patient-in-Phase-I-Clinical-Trial-of-DualPayload-ADC-CLIO8221-in-Advanced-HER2Expressing-Solid-Tumors

CLIO-8221 - Callio Therapeutics

https://www.globenewswire.com/news-release/2026/03/24/3261154/0/en/Callio-Therapeutics-Doses-First-Patient-in-Phase-I-Clinical-Trial-of-Dual-Payload-ADC-CLIO-8221-in-Advanced-HER2-Expressing-Solid-Tumors.html

Mar 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next